AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Horizon Therapeutics plc to Participate in Upcoming Investor Conferences

November 13, 2019

DUBLIN--(BUSINESS WIRE)--Nov 13, 2019--

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following upcoming conferences:

Stifel 2019 Healthcare Conference

Jefferies 2019 London Healthcare Conference

Piper Jaffray 31 st Annual Healthcare Conference

The conference presentations will be webcast live and may be accessed by visiting Horizon’s website at http://ir.horizontherapeutics.com. A replay of the webcasts will be available for the events.

About Horizon

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com, follow us @HorizonNews on Twitter, like us on Facebook or explore career opportunities on LinkedIn.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191113005859/en/

CONTACT: Investors:

Tina Ventura

Senior Vice President,

Investor Relations

investor-relations@horizontherapeutics.comRuth Venning

Executive Director,

Investor Relations

investor-relations@horizontherapeutics.comU.S. Media:

Geoff Curtis

Executive Vice President,

Corporate Affairs & Chief Communications Officer

media@horizontherapeutics.comIreland Media:

Ray Gordon

Gordon MRM

ray@gordonmrm.ie

KEYWORD: NEW YORK NORTH AMERICA UNITED STATES IRELAND UNITED KINGDOM EUROPE

INDUSTRY KEYWORD: HEALTH GENERAL HEALTH

SOURCE: Horizon Therapeutics plc

Copyright Business Wire 2019.

PUB: 11/13/2019 04:15 PM/DISC: 11/13/2019 04:15 PM

http://www.businesswire.com/news/home/20191113005859/en